Sun Pharma Advanced Research Company Ltd. – Product Pipeline Review

Global Markets Direct’s, ‘Sun Pharma Advanced Research Company Ltd. – Product Pipeline Review – 2016’, provides an overview of the Sun Pharma Advanced Research Company Ltd.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Sun Pharma Advanced Research Company Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Sun Pharma Advanced Research Company Ltd.

The report provides overview of Sun Pharma Advanced Research Company Ltd. including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Sun Pharma Advanced Research Company Ltd.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Sun Pharma Advanced Research Company Ltd.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Sun Pharma Advanced Research Company Ltd.’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Sun Pharma Advanced Research Company Ltd.

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Sun Pharma Advanced Research Company Ltd.’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

Sun Pharma Advanced Research Company Ltd. Snapshot 6

Sun Pharma Advanced Research Company Ltd. Overview 6

Key Information 6

Key Facts 6

Sun Pharma Advanced Research Company Ltd. - Research and Development Overview 7

Key Therapeutic Areas 7

Sun Pharma Advanced Research Company Ltd. - Pipeline Review 10

Pipeline Products by Stage of Development 10

Pipeline Products - Monotherapy 11

Pipeline Products - Combination Treatment Modalities 12

Pipeline Products - Partnered Products 13

Partnered Products/Combination Treatment Modalities 14

Sun Pharma Advanced Research Company Ltd. - Pipeline Products Glance 15

Sun Pharma Advanced Research Company Ltd. - Late Stage Pipeline Products 15

Pre-Registration Products/Combination Treatment Modalities 15

Filing rejected/Withdrawn Products/Combination Treatment Modalities 16

Phase III Products/Combination Treatment Modalities 17

Sun Pharma Advanced Research Company Ltd. - Clinical Stage Pipeline Products 18

Phase II Products/Combination Treatment Modalities 18

Phase I Products/Combination Treatment Modalities 19

Sun Pharma Advanced Research Company Ltd. - Early Stage Pipeline Products 20

Preclinical Products/Combination Treatment Modalities 20

Discovery Products/Combination Treatment Modalities 21

Sun Pharma Advanced Research Company Ltd. - Drug Profiles 22

latanoprost 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

baclofen ER 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

tildrakizumab 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

paclitaxel albumin free 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

tizanidine hydrochloride ER 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

SUNK-706 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

(fluticasone propionate + salmeterol xinafoate) 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

docetaxel 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

octreotide acetate SR 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

SUN-0597 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

brimonidine tartrate 33

Product Description 33

Mechanism of Action 33

R&D Progress 33

hydrocodone bitartrate 34

Product Description 34

Mechanism of Action 34

R&D Progress 34

minocycline hydrochloride 35

Product Description 35

Mechanism of Action 35

R&D Progress 35

morphine sulfate 36

Product Description 36

Mechanism of Action 36

R&D Progress 36

oxycodone hydrochloride 37

Product Description 37

Mechanism of Action 37

R&D Progress 37

Gene Therapy for Ocular Diseases 38

Product Description 38

Mechanism of Action 38

R&D Progress 38

Sun Pharma Advanced Research Company Ltd. - Pipeline Analysis 39

Sun Pharma Advanced Research Company Ltd. - Pipeline Products by Target 39

Sun Pharma Advanced Research Company Ltd. - Pipeline Products by Route of Administration 40

Sun Pharma Advanced Research Company Ltd. - Pipeline Products by Molecule Type 41

Sun Pharma Advanced Research Company Ltd. - Pipeline Products by Mechanism of Action 42

Sun Pharma Advanced Research Company Ltd. - Recent Pipeline Updates 44

Sun Pharma Advanced Research Company Ltd. - Dormant Projects 46

Sun Pharma Advanced Research Company Ltd. - Discontinued Pipeline Products 47

Discontinued Pipeline Product Profiles 47

baclofen ER 47

RBx-10558 47

SUN-0597 47

SUN-09 IR 48

SUN-09 Slow Release 48

SUN-1334H 48

SUN-44 48

SUNL-731 48

Sun Pharma Advanced Research Company Ltd. - Locations And Subsidiaries 49

Head Office 49

Appendix 50

Methodology 50

Coverage 50

Secondary Research 50

Primary Research 50

Expert Panel Validation 50

Contact Us 50

Disclaimer 51

List of Tables

List of Tables

Sun Pharma Advanced Research Company Ltd., Key Information 6

Sun Pharma Advanced Research Company Ltd., Key Facts 6

Sun Pharma Advanced Research Company Ltd. – Pipeline by Indication, 2016 8

Sun Pharma Advanced Research Company Ltd. – Pipeline by Stage of Development, 2016 10

Sun Pharma Advanced Research Company Ltd. – Monotherapy Products in Pipeline, 2016 11

Sun Pharma Advanced Research Company Ltd. – Combination Treatment Modalities in Pipeline, 2016 12

Sun Pharma Advanced Research Company Ltd. – Partnered Products in Pipeline, 2016 13

Sun Pharma Advanced Research Company Ltd. – Partnered Products/ Combination Treatment Modalities, 2016 14

Sun Pharma Advanced Research Company Ltd. – Pre-Registration, 2016 15

Sun Pharma Advanced Research Company Ltd. – Filing rejected/Withdrawn, 2016 16

Sun Pharma Advanced Research Company Ltd. – Phase III, 2016 17

Sun Pharma Advanced Research Company Ltd. – Phase II, 2016 18

Sun Pharma Advanced Research Company Ltd. – Phase I, 2016 19

Sun Pharma Advanced Research Company Ltd. – Preclinical, 2016 20

Sun Pharma Advanced Research Company Ltd. – Discovery, 2016 21

Sun Pharma Advanced Research Company Ltd. – Pipeline by Target, 2016 39

Sun Pharma Advanced Research Company Ltd. – Pipeline by Route of Administration, 2016 40

Sun Pharma Advanced Research Company Ltd. – Pipeline by Molecule Type, 2016 41

Sun Pharma Advanced Research Company Ltd. – Pipeline Products by Mechanism of Action, 2016 42

Sun Pharma Advanced Research Company Ltd. – Recent Pipeline Updates, 2016 44

Sun Pharma Advanced Research Company Ltd. – Dormant Developmental Projects,2016 46

Sun Pharma Advanced Research Company Ltd. – Discontinued Pipeline Products, 2016 47

List of Figures

List of Figures

Sun Pharma Advanced Research Company Ltd. – Pipeline by Top 10 Indication, 2016 8

Sun Pharma Advanced Research Company Ltd. – Pipeline by Stage of Development, 2016 10

Sun Pharma Advanced Research Company Ltd. – Monotherapy Products in Pipeline, 2016 11

Sun Pharma Advanced Research Company Ltd. – Partnered Products in Pipeline, 2016 13

Sun Pharma Advanced Research Company Ltd. – Pipeline by Top 10 Target, 2016 39

Sun Pharma Advanced Research Company Ltd. – Pipeline by Route of Administration, 2016 40

Sun Pharma Advanced Research Company Ltd. – Pipeline by Molecule Type, 2016 41

Sun Pharma Advanced Research Company Ltd. – Pipeline Products by Top 10 Mechanism of Action, 2016 42

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports